The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use

The clinical case of the successful use of the myocardial cytoprotector trimetazidine as a universal anti-ischemic agent in a patient with hemodynamic angina due to myocardial bridging is described. The pathogenetic rationale for this prescription is presented.

Saved in:
Bibliographic Details
Main Authors: O. V. Tsygankova, L. D. Latyntseva, T. I. Batluk, D. Yu. Platonov, N. M. Akhmedzhanov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2019-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
off-label use
hemodynamic angina
trimetazidine
Online Access:https://cardiovascular.elpub.ru/jour/article/view/2341
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items